Contrast Echocardiography Imaging

Clinical trial pipeline · Data from ClinicalTrials.gov

See which Contrast Echocardiography Imaging trials you may qualify for

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

RecruitingNot Applicable

NCT04446858

Non-invasive Evaluation of the Predictive Value of CEUS and SWE in ACLF, Renal Failure and Hepatorenal Syndrome

Evaluation of non-invasive prognostic parameters in patients developing ACLF and renal failure in patients receiving and not receiving transjugular intrahepatic…

Germany1,000 participantsStarted 2021-01-01

All recent trials (21 shown)

Not Yet RecruitingEarly Phase 1

NCT07538544

MCE Molecular Imaging for ICI Myocarditis

Inflammation of the heart (myocarditis) is a serious condition that can cause heart failure, abnormal heart rhythms, cardiac arrest, and death. A new class of m…

United States30 participantsStarted 2026-07-01

Treatment: Myocardial contrast echocardiography molecular imaging for inflammation

CompletedNot Applicable

NCT04649034

Intraventricular Stasis In Cardiovascular Disease

This study is designed to quantify the ventricular stasis in patients with different forms of cardiomyopathy and at risk of stroke (ischemic, non-ischemic dilat…

Spain258 participantsStarted 2020-11-24

Treatment: Doppler echocardiogram exam, Cardiac magnetic resonance

Contrast Echocardiography Imaging

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

Non-invasive Evaluation of the Predictive Value of CEUS and SWE in ACLF, Renal Failure and Hepatorenal Syndrome

All recent trials (21 shown)

MCE Molecular Imaging for ICI Myocarditis

Intraventricular Stasis In Cardiovascular Disease

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

Non-invasive Evaluation of the Predictive Value of CEUS and SWE in ACLF, Renal Failure and Hepatorenal Syndrome

All recent trials (21 shown)

MCE Molecular Imaging for ICI Myocarditis

Intraventricular Stasis In Cardiovascular Disease

Contrast Specific Echocardiogram Versus Left Ventricular Opacification (LVO) Imaging Settings

Regadenoson Real Time Perfusion Imaging Trial-Optison

Prospective Analysis and Comparison of Stress Echo to Real-Time Myocardial Contrast Stress Echo

Real Time Myocardial Contrast Echocardiography and Dobutamine Stress Perfusion Magnetic Resonance Imaging

Natural History of Coronary Atherosclerosis in Real-World Stable Chest Pain Patients Underwent Computed Tomography Angio…

Real-Time Myocardial Perfusion Echocardiography in the ICU

Perfusion Imaging With Myocardial Contrast Echocardiography in HCM

Assessment of Wall Thickness in Hypertrophic Cardiomyopathy

Ischemic Memory Imaging With Myocardial Contrast Echocardiography

Enhancement of Contrast Opacification for Echocardiographic Imaging of the Right Heart and Shunts

Results of Tc99m-Maraciclatide Scintigraphy in Subjects With Diabetes Mellitus and Heart Failure With Preserved Left Ven…

DMP115 in Patients With an Ejection Fraction Between 25%-40% to Evaluate the Use of Contrast Echocardiography to Assess…

Myocardial Perfusion in Type 2 Diabetes

Evaluation and Optimization of PB127 Myocardial Perfusion Echocardiography on Ultrasound Systems

Prognostic Assessment of Contrast Echocardiography (PACE Study)

Acquiring Consensus for Contrast Echocardiography System Settings - ACCESS Study

Phase 3 Imaging and Safety Study of AI-700 in Patients With Suspected Coronary Artery Disease Undergoing SPECT Imaging

Phase 3 Safety and Imaging Study of AI-700 in Patients With Suspected Coronary Artery Disease Undergoing Coronary Angiog…